Exploring functional metabolites in preterm infants

Aim Metabolomics is the study of small molecules that represent the functional end points of cellular reactions that can impact health. Necrotising enterocolitis (NEC) and late onset sepsis (LOS) are the main cause of death in preterm infants surviving the initial days of life. Methods This review will explore and summarise the current literature exploring metabolomics in preterm infants. Results There are a relatively limited number of studies investigating metabolomics in preterm infants with NEC and/or LOS and matched controls. Nonetheless, it is evident across longitudinally age-related metabolomic studies that there are significant changes in metabolite profiles post-partum and over the first year of life. Existing studies have reported associations between the metabolite profiles of serum, urine and stool in health and disease in preterm infants. Although some studies have found selected metabolites are associated with disease, the specific metabolites vary from study to study, and larger studies are required. Excitingly, recent work has also begun to untangle how microbially produced metabolites can impact immunoregulation of the infant. Conclusion Metabolic exploration is an emerging research area with huge potential for developing novel biomarkers and better understanding disease processes in preterm infants.

Automated summary

Metabolomics in preterm infants, particularly focusing on NEC and LOS, is a relatively new field with promising potential for identifying novel biomarkers and understanding disease processes. Studies have shown significant changes in metabolite profiles post-partum and throughout the first year of life, with associations between metabolites in serum, urine, and stool in health and disease. Further research is needed to identify specific metabolites associated with disease and the impact of microbially produced metabolites on immunoregulation in infants.